Inventors:
- Burlington NC, US
Jodi Weidler - Foster City CA, US
Jeff Sperinde - El Granada CA, US
Mojgan Haddad - Orinda CA, US
Michael Bates - San Carlos CA, US
John William Winslow - El Granada, IS
Xueguang Jin - Fremont CA, US
Gerald J. Wallweber - Foster City CA, US
Jennifer W. Cook - San Mateo CA, US
Gundo Diedrich - South San Francisco CA, US
Laurie Goodman - El Granada CA, US
Ali Mukherjee - Millbrae CA, US
Gordon Parry - Oakland CA, US
Stephen J. Williams - San Carlos CA, US
Assignee:
Laboratory Corporation of America Holdings - Burlington NC
International Classification:
C07K 16/32
G01N 33/50
G01N 33/68
A61P 35/00
G01N 33/574
G01N 33/74
C12Q 1/6886
A61K 45/06
Abstract:
The present invention relates generally to methods of accurately quantifying HER2 and/or p95 expression in subjects with a HER2 positive cancer and indicating the risk of brain relapse in such patients.